This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National University of Singapore. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hwee Goon Tay: Innovator in Retinal Progenitor Production
Introduction
Hwee Goon Tay is a prominent inventor based in Singapore, known for his significant contributions to the field of stem cell research. His innovative work focuses on the production of retinal progenitors and mature photoreceptor cells, which are crucial for advancements in regenerative medicine and vision restoration.
Latest Patents
Hwee Goon Tay holds a patent titled "Systems and methods for producing retinal progenitors." This patent describes a method for differentiating human embryonic stem cells on a surface with a laminin matrix made of two laminins. One laminin is laminin-521, while the other can be either laminin-323 or laminin-523. The stem cells plated on this substrate can be differentiated using various cell culture mediums to obtain retinal progenitors and mature photoreceptor cells. This innovative approach has the potential to enhance the treatment of retinal diseases.
Career Highlights
Hwee Goon Tay is affiliated with the National University of Singapore, where he conducts his research and development in stem cell technology. His work has garnered attention for its potential applications in treating vision impairments and advancing our understanding of retinal biology.
Collaborations
Hwee Goon Tay has collaborated with notable colleagues, including Aida Moreno Moral and Karl Tryggvason. These collaborations have contributed to the advancement of research in the field of retinal progenitor production.
Conclusion
Hwee Goon Tay's innovative work in stem cell research and his patent on retinal progenitor production highlight his significant contributions to the field. His research has the potential to impact the future of regenerative medicine and vision restoration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
